In particular, up to 98% of G2/M genes downregulated upon NFYC-AS1 silencing showed significant upregulation in all cancer histotypes, suggesting that NFYC-AS1 impacts on cancer-relevant targets. This evidence concerns the gene NFYC and cancer.